Letters Screening for chlamydia

Opportunistic or population register based programmes for chlamydia screening?

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e5887 (Published 04 September 2012) Cite this as: BMJ 2012;345:e5887
  1. Angie Bone, director, National Chlamydia Screening Programme1,
  2. Kate Soldan, senior scientist, monitoring and evaluation1,
  3. Sarah Woodhall, surveillance scientist, monitoring and evaluation1,
  4. Janette Clarke, chair, National Chlamydia Screening Advisory Group2,
  5. O Noel Gill, head1
  1. 1HIV and STI Department, Health Protection Agency, London NW9 5EQ, UK
  2. 2Department of Genitourinary Medicine, Leeds Teaching Hospitals Trust, Leeds General Infirmary, Leeds LS1 3EX, UK
  1. angie.bone{at}hpa.org.uk

The trial of population register based screening for asymptomatic chlamydia infection in the Netherlands will rekindle debate about how to screen young adults and its value.1 2 Participation was lower than hoped, decreased over time, and was less than needed to have a detectable impact on outcomes. Because the trial assessed the additional effect of population register based invitations, not …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe